{"id":4732,"date":"2022-01-03T17:45:48","date_gmt":"2022-01-03T16:45:48","guid":{"rendered":"https:\/\/www.miph.gov.dz\/?p=4732"},"modified":"2022-01-05T15:46:34","modified_gmt":"2022-01-05T14:46:34","slug":"le-ministere-de-lindustrie-pharmaceutique-au-chevet-des-patients-atteints-de-mucoviscidose","status":"publish","type":"post","link":"https:\/\/www.miph.gov.dz\/en\/le-ministere-de-lindustrie-pharmaceutique-au-chevet-des-patients-atteints-de-mucoviscidose\/","title":{"rendered":"Le Minist\u00e8re de l\u2019Industrie Pharmaceutique au chevet des patients atteints de Mucoviscidose"},"content":{"rendered":"<p>Dans le cadre de l\u2019accompagnement et du soutien continu aux efforts\u00a0 de la soci\u00e9t\u00e9 civile et particuli\u00e8rement \u00e0 l\u2019action associative en faveur des malades, le Ministre de l\u2019Industrie Pharmaceutique le Dr Abderrahmane Djamel Lotfi Benbahmed a re\u00e7u ,lundi 03 janvier\u00a0 2021, une d\u00e9l\u00e9gation de l&rsquo;association nationale de la mucoviscidose conduite par son Pr\u00e9sident Bouchiche Houssam Eddine.<\/p>\n<div id='gallery-1' class='gallery galleryid-4732 gallery-columns-3 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/www.miph.gov.dz\/en\/le-ministere-de-lindustrie-pharmaceutique-au-chevet-des-patients-atteints-de-mucoviscidose\/muciviscidose-2\/'><img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Muciviscidose-2-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" srcset=\"https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Muciviscidose-2-150x150.jpg 150w, https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Muciviscidose-2-75x75.jpg 75w, https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Muciviscidose-2-45x45.jpg 45w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/www.miph.gov.dz\/en\/le-ministere-de-lindustrie-pharmaceutique-au-chevet-des-patients-atteints-de-mucoviscidose\/mucoviscdose-1\/'><img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-1-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" srcset=\"https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-1-150x150.jpg 150w, https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-1-75x75.jpg 75w, https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-1-45x45.jpg 45w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/www.miph.gov.dz\/en\/le-ministere-de-lindustrie-pharmaceutique-au-chevet-des-patients-atteints-de-mucoviscidose\/mucoviscdose-3\/'><img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-3-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" srcset=\"https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-3-150x150.jpg 150w, https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-3-75x75.jpg 75w, https:\/\/www.miph.gov.dz\/en\/wp-content\/uploads\/2022\/01\/Mucoviscdose-3-45x45.jpg 45w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div><\/figure>\n\t\t<\/div>\n\n<p>Un certain nombre de pr\u00e9occupations ont \u00e9t\u00e9 pos\u00e9es ainsi que les initiatives et les propositions que pouvait apporter le Minist\u00e8re de l\u2019Industrie Pharmaceutique pour am\u00e9liorer la prise en charge de cette maladie rares, \u00e0 travers la concertation avec le comit\u00e9 d\u2019expert clinicien pour actualiser le protocole th\u00e9rapeutique et prioriser l\u2019enregistrement des m\u00e9dicaments innovants en vue d\u2019assurer une disponibilit\u00e9 continue des produits pharmaceutiques indispensables aux enfants malades.<\/p>\n<p>Les discussions ont \u00e9galement port\u00e9 sur la n\u00e9cessaire actualisation de la prise en charge de cette maladie h\u00e9r\u00e9ditaire notamment pour les probl\u00e9matiques de prix de r\u00e9f\u00e9rence de certains m\u00e9dicaments.<\/p>\n<p>Sur instructions de Mr le Ministre de l\u2019Industrie Pharmaceutique, l\u2019observatoire national de veille sur la disponibilit\u00e9 des produits pharmaceutiques, consacrera une session, en\u00a0 collaboration avec le comit\u00e9 des experts cliniciens, pour assurer le suivis des m\u00e9dicaments indispensables aux patients atteints de mucoviscidose.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans le cadre de l\u2019accompagnement et du soutien continu aux efforts\u00a0 de la soci\u00e9t\u00e9 civile et particuli\u00e8rement \u00e0 l\u2019action associative en faveur des malades, le Ministre de l\u2019Industrie Pharmaceutique le Dr Abderrahmane Djamel Lotfi Benbahmed a re\u00e7u ,lundi 03 janvier\u00a0 2021, une d\u00e9l\u00e9gation de l&rsquo;association nationale de la mucoviscidose conduite par son Pr\u00e9sident Bouchiche Houssam [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4734,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-4732","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite"],"_links":{"self":[{"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/posts\/4732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/comments?post=4732"}],"version-history":[{"count":1,"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/posts\/4732\/revisions"}],"predecessor-version":[{"id":4736,"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/posts\/4732\/revisions\/4736"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/media\/4734"}],"wp:attachment":[{"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/media?parent=4732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/categories?post=4732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.miph.gov.dz\/en\/wp-json\/wp\/v2\/tags?post=4732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}